Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
12 Mar 2026
Delgocitinib Cream Improves Quality of Life in Hand Eczema
Delgocitinib cream significantly improved quality of life in adults with moderate to severe Chronic Hand Eczema (CHE) in pooled phase III trial data.
11 Mar 2026
Ixekizumab Shows Strong Response in Juvenile Arthritis
Ixekizumab achieved high clinical response rates in children with juvenile idiopathic arthritis in a Phase III trial.
10 Mar 2026
Stem Cell Therapies Show Promise For Silicosis
STEM cell therapy is emerging as a promising approach for silicosis, an irreversible fibrotic lung disease caused by chronic exposure to respirable crystalline silica.
9 Mar 2026
Abrocitinib Shows Long-Term Success in Atopic Dermatitis
Abrocitinib appears durable and well tolerated in patients with moderate-to-severe atopic dermatitis (AD), also known as eczema, according to a 2-year retrospective real-world study.
9 Mar 2026
New Score Measures Pediatric Rheumatology Care Outcomes
A new transition success score for pediatric rheumatology patients provides a structured method to evaluate outcomes when adolescents move from pediatric to adult care.
7 Mar 2026
Cardiorespiratory Fitness Linked to Lower COVID-19 Hospitalization
Higher cardiorespiratory fitness linked to lower COVID-19 hospitalization risk, but not SARS-CoV-2 infection, in a large population cohort.
4 Mar 2026
Second-Line Pazopanib Yields Positive Responses in Angiosarcomas
Pazopanib shows activity and manageable safety in paclitaxel-pretreated cutaneous angiosarcoma, offering a potential second-line therapy option.
4 Mar 2026
Manual Acupuncture Shown to Alleviate Rheumatoid Arthritis Pain
Manual acupuncture alleviates rheumatoid arthritis pain by targeting the spinal microglia via NF-κB/STAT3.
←
1
2
3
4
5
6
We’ve noticed you’re accessing
from
North/South America.
View
View